GZMB and myalgic encephalomeyelitis/chronic fatigue syndrome: There was no significant difference between CFS/ME patients and NFC for granzyme A and granzyme B prior to incubation with Rituximab and following overnight incubation with Rituximab at 10 μg/ml.